跳至主要内容
临床试验/NCT00266266
NCT00266266已完成不适用

Human Papilloma Virus DNA Self-Test

University of Louisville1 个研究点 分布在 1 个国家目标入组 171 人开始时间: 2004年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
171
试验地点
1
主要终点
HPV DNA self-testing device to detect disease in patients with abnormal Pap smear

研究概览

简要总结

HPV DNA testing by a clinician has been shown to be highly sensitive in detecting cervical disease. Can we prove that HPV self-testing will be sufficiently sensitive to detect disease in high risk population who for various reasons would not have routine pap smear screening?

详细描述

Women between the ages of 18 years to post-menopausal with documented abnormal pap smear atypical squamous cells of undetermined significance and higher will be enrolled into the study. Patients will be taught how to collect vaginal samples with dacron swab and vaginal tampons by means of instructional video and manufacturer's instruction guide respectively. Physicians will perform pap smear and colposcopy. All samples will be sent to the University of Louisville lab for processing for HPV DNA detection by Hybrid capture 2 method.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Abnormal pap smear ASCUS or higher
  • Age 18-postmenopausal

排除标准

  • Less than 18 years old
  • Prior hysterectomy
  • Use of corticosteroids
  • HIV positive

结局指标

主要结局

HPV DNA self-testing device to detect disease in patients with abnormal Pap smear

时间窗: Patient will self-test immediately prior to their standard physician papsmear

To assess the concordance of HPV DNA self-testing device to detect disease in patients with abnormal Pap smear. Patients with a positive HPV Self-test by vaginal swab or vaginal tampon will be compared to the physician test results for concordance. Following patient self-sample collection, physician will collect cervical samples using a spatula. A self testing device which patients can use at their convenience will be beneficial in decreasing the incidence of cervical cancer in Kentucky.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验